| Financial Year |
March 31 2023 |
| Monetary Funds |
156,697,111.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
61,368,818.08 |
| Advances to Suppliers |
14,220,748.33 |
| Other Receivables |
280,483,260.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
14,750,215.63 |
| Dividend Receivable |
-- |
| Inventories |
2,262,201,632.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,060,963.87 |
| Total Current Assets |
3,043,673,896.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
103,868,184.54 |
| Long-term Equity Investment |
188,015,807.52 |
| Investment Properties |
2,514,531,868.29 |
| Fixed Assetes |
55,341,486.64 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,233,053.72 |
| R&D expenses |
-- |
| Goodwill |
264,183,180.83 |
| Long-Term Deferred and Prepaid Expenses |
813,111,237.37 |
| Deferred Income Tax Assets |
168,083,277.98 |
| Other Non-Current Assets |
34,393,952.10 |
| Sub-Total of Non-Current Assets |
5,709,163,769.42 |
| Total Assets |
8,752,837,665.89 |
| Short-Term Loans |
299,440,228.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
209,870,134.67 |
| Accounts Received In Advance |
4,919,872.63 |
| Employee Compensation Payable |
1,577,786.86 |
| Taxes Payable |
87,059,505.95 |
| Interest Payable |
-- |
| Dividend Payable |
4,269,659.99 |
| Other payables |
539,906,815.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
937,160,501.25 |
| Other Current Liabilities |
7,351.20 |
| Sub-Total of Current Liabilities |
2,167,597,077.58 |
| Long-term Loans |
2,358,074,421.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,266,358.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,319,678,576.09 |
| Total Liabilities |
5,487,275,653.67 |
| Paid-In Capital(Or Share Stock) |
2,509,244,757.00 |
| Capital Surplus |
954,125,051.27 |
| Surplus Reserve |
46,534,036.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-341,758,541.04 |
| Minority Stockholder's Interest |
97,521,370.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,168,040,641.58 |
| Owner's Equity（Stockholder's Equity） |
3,265,562,012.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,752,837,665.89 |
